NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Glenn Yiu
University of California Davis - Davis / United States
Engineering & Technology / Nanoscience and Nanotechnology
AD Scientific Index ID: 1747253
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Glenn Yiu's MOST POPULAR ARTICLES
1-)
Glial inhibition of CNS axon regenerationG Yiu, Z HeNature Reviews Neuroscience 7 (8), 617-627, 200617252006
2-)
A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitorsJB Park, G Yiu, S Kaneko, J Wang, J Chang, Z HeNeuron 45 (3), 345-351, 20055582005
3-)
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double …JS Heier, AM Khanani, CQ Ruiz, K Basu, PJ Ferrone, C Brittain, ...The Lancet 399 (10326), 729-740, 20224542022
4-)
EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycansV Koprivica, KS Cho, JB Park, G Yiu, J Atwal, B Gore, JA Kim, E Lin, ...Science 310 (5745), 106-110, 20054462005
5-)
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two …CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ...The Lancet 399 (10326), 741-755, 20223762022
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept